Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology
The Photon Counting Detectors (PCD), as the core technology of PCCT, differ significantly from traditional Energy Integrating Detectors (EID). Traditional CT scanners require X-ray photons to first be converted into visible light, then into electrical signals. In contrast, the PCCT detector employs semiconductor materials, where X-ray photons excite electrons, creating electron-hole pairs proportional to photon energy. Charge carriers from the pairs are separated by an electric field to generate electrical pulses. Application-Specific Integrated Circuits (ASIC) categorize these pulses by energy bins, enabling precise photon counting and energy resolution. This breakthrough provides crucial technical support for multi-energy spectral imaging, significantly enhancing the diagnostic value of medical imaging.
Currently, the PCCT detectors primarily utilize three materials: Cadmium Zinc Telluride (CdZnTe or CZT), Cadmium Telluride (CdTe), and Deep Silicon. CZT is emerging as a breakthrough for next-generation medical imaging technology due to its outstanding detection capabilities. The core value of VITA Genesis lies not only in adopting a detector solution based on the CZT, but more importantly in pioneering the mastery of PCCT's full vertical integration technology. This includes ultra-high purity metals purification and compounding, single crystal growth and processing, component design and development, CT system integration, and imaging algorithm development, establishing a global paradigm in the field of PCCT.
Contact: yuman.wu@alltechmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vital-materials-released-quantum-flux-photon-counting-ct-pcct-full-vertical-integration-technology-302534203.html
SOURCE Vital Materials
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNBC
3 minutes ago
- CNBC
CNBC Daily Open: Tech sell-off? Investors could just be taking profit and enjoying the summer
If you have any U.S. technology stocks in your portfolio (and let's face it, who doesn't?), you might want to look away. For the second day in a row, tech stocks dragged markets lower, with the Nasdaq Composite slipping 0.67%. Juggernauts such as Apple, Amazon and Alphabet were more meh-nificent than magnificent, falling more than 1%. Palantir — the standout S&P 500 stock, having more than doubled so far this year — had its sixth consecutive day in the red and lost its place among a ranking of the 20 most valuable U.S. companies. While Palantir's slide was partly triggered by a report from short seller Andrew Left's Citron Research, which called the company "detached from fundamentals and analysis," there was no single trigger for the broader pullback. Investors could have been spooked by OpenAI CEO Sam Altman's caution about an AI bubble forming, although some analysts dispute that assertion. "In our view the tech bull cycle will be well intact at least for another 2-3 years," said Wall Street tech bull Dan Ives. Or it could be something benign, like traders locking in profits. "Tech stocks," said Carol Schleif, chief market strategist at BMO Private Wealth, "have had an incredibly strong run – with some up over 80% since the early April lows." Summer, after all, is far from over. Some investors might have just wanted to cash out for another round of margaritas. Fed officials divided over inflation and employment worries. Central bank governors generally agreed there were risks on both sides. But a couple — breaking from the majority — saw the labor market woes as more pressing, according to minutes of the Fed's July meeting. No new solar or wind power projects, Trump says. Renewable energy projects will no longer receive approval, Trump posted Wednesday on Truth Social. His comment comes after the administration already tightened federal permitting last month. Meta Platforms freezes hiring artificial intelligence talent. The tech giant had in recent months been splashing out eye-watering amounts of money — up to $100 million on signing bonuses — to poach AI employees at other firms. But it appears that cash pool's left to dry for now. Fourth day of losses for the S&P 500. Technology stocks declined on Wednesday, with Palantir having its sixth straight losing day. Asia-Pacific markets were mostly lower Thursday — but Australia's S&P/ASX 200 rose to break the 9,000 level for the first time. [PRO] The Fed is expected to cut just as markets trade at highs. This is what tends to happen when both factors coincide, according to Goldman Sachs research. Red carpet for Putin, trade relief for China, penalties on India: Inside Trump's peculiar policy playbook U.S. President Donald Trump is pursuing an unusual strategy — courting Russian President Vladimir Putin, holding fire on Beijing, all the while turning the screws on India. Despite India being one of the earliest nations to engage in negotiations with the Trump administration, there is still no sign of it sealing a deal with America. New Delhi is now also staring at a secondary tariff of 25% or a "penalty" for its purchases of Russian oil that is set to come into effect later this month.
Yahoo
30 minutes ago
- Yahoo
OffSec and Deloitte Collaborate to Strengthen Asia's Cyber Defences Through Workforce Development
NEW YORK, Aug. 21, 2025 /PRNewswire/ -- OffSec Services Ltd ("OffSec"), a leading global provider of cybersecurity training and certifications, is pleased to announce a strategic collaboration with Deloitte. This partnership will deliver advanced, real-world cybersecurity training programs across Asia, directly addressing the rising cyber threats and the ongoing shortage of skilled cybersecurity professionals. The collaboration unites OffSec's reputation for developing cybersecurity professionals with a focus on technical skill and adversary mindset, with Deloitte's enterprise cybersecurity expertise and regional insights. Together, OffSec and Deloitte aim to provide a high-impact training experience that equips security practitioners, enterprise teams, and aspiring professionals with the offensive and defensive capabilities needed to tackle today's most urgent security challenges. "Cybersecurity today demands more than awareness and a modern tech stack — it requires hands-on capability, continuous upskilling, and readiness for real-world, real-time threats. Through this exciting strategic partnership, OffSec brings our industry-leading simulation and skills development, combined with Deloitte's deep client, industry, and regulatory insight. Together, we're enabling more effective large-scale cyber transformations by building resilient, enterprise-grade security teams prepared to meet the evolving threat landscape." said Matt Collins, VP of APAC, OffSec. The training programmes will cover a wide range of advanced topics, including penetration testing, ethical hacking, exploit development, application and infrastructure security, and incident response. Courses will be delivered by certified instructors and conducted through OffSec's proven hands-on lab environments, while also incorporating Deloitte's business-contextualised scenarios and case studies. This ensures that participants not only gain technical proficiency but are also able to apply that knowledge in real-world operational settings. For organisations facing growing regulatory scrutiny and increasingly sophisticated attacks, the collaboration offers a scalable solution to upskilling their cybersecurity teams with globally respected certifications and battle-tested techniques. The initial rollout will begin in Singapore, with future expansion planned across key Asia Pacific markets. "As the threat environment is becoming increasingly complex and the talent gap is growing wider, this collaboration with OffSec addresses both challenges by providing practical, career-relevant training that builds technical depth while helping organisations establish a culture of security that is grounded in operational capability," said Lim Kim Hwee, Executive Director, Deloitte Learning Solutions. OffSec and Deloitte's shared mission through this collaborative effort is to elevate the cybersecurity profession across the region by making expert-level training more accessible, relevant, and aligned with the evolving needs of enterprises and regulators. With this collaboration, the two organisations are setting a new standard for how cybersecurity talent development should be approached: technically rigorous, business-aware, and regionally informed. About OffSec Services LtdOffSec is the leading provider of continuous professional and workforce development, training, and education for cybersecurity practitioners. OffSec's distinct pedagogy and practical, hands-on learning help organizations fill the infosec talent gap by training their teams on today's most critical skills. With the OffSec Learning Library featuring 7,000 hours of content, including over 1,800 videos, and 4,200+ labs. OffSec demonstrates its commitment to empowering individuals and organizations to fight cyber threats with indispensable cybersecurity skills and resources. OffSec also funds and maintains Kali Linux, the leading operating system for penetration testing, ethical hacking, and network security assessments. For more information, visit and follow us on X and LinkedIn. For media inquiries, please contact:Contact Person: Damian GohEmail: | View original content: SOURCE OffSec Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30 minutes ago
- Yahoo
Japan's Takeda weighs India for global trials to speed up drug launches
By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting global clinical trials in India to accelerate the launch of its innovative drugs in the world's most populous nation, its India head told Reuters. The plan comes at a time when India's clinical trials market is growing, powered by diverse patient pools, cost efficiency, and a fast-growing hospital network. Grand View Research expects the market to exceed $2 billion by 2030. "India is a strategic growth market for Takeda, and we are making significant long-term investments... in terms of innovation and building capabilities," said Annapurna Das, the general manager of Takeda's India operations. She did not share financial details of the investments. "We're exploring the opportunity of leveraging India's clinical trial ecosystem," Das said. Takeda is also open to partnering with local academia, healthcare providers and technology firms in India for innovation, Das said, without sharing more specifics. "At this point of time, we are still kind of exploring and evaluating how we want to go ahead," she added. Takeda's eventual aim is to integrate India's research and development "ecosystem" into its global pipeline and expand Indian patients' access to cutting-edge therapies in oncology, neuroscience, gastrointestinal health, and inflammation. The Japanese drugmaker aims to launch key cancer drugs over the next two to three years in India, with a lung cancer drug ready to hit the market this year. There's also a dengue vaccine in its launch pipeline, for which Takeda has tied up with local vaccine maker Biological E., and is awaiting approval from India's drug regulator. Takeda established an innovation centre in Bengaluru, dubbed India's "Silicon Valley", earlier this year to tap the country's tech talent to power its global digital transformation. The centre is expanding to have 750 staff working in AI, data science, engineering, and design, from just over 500 employees currently. Sign in to access your portfolio